非常抱歉,
你要访问的页面不存在,
非常抱歉,
你要访问的页面不存在,
非常抱歉,
你要访问的页面不存在,
验证码:
职称:professor
所属学校:Massachusetts Institute of Technology
所属院系:Neuroscience
所属专业:Neuroscience
联系方式:617-324-3085
Engineering matter and mind Ed Boyden develops new strategies for analyzing and engineering brain circuits, using synthetic biology, nanotechnology, chemistry, electrical engineering, and optics to develop broadly applicable methodologies that reveal fundamental mechanisms of complex brain processes. A major goal of his current work is the development of technologies for controlling nerve cells using light – a powerful new technology known as optogenetics that is opening the door to new treatments for conditions such as epilepsy, Parkinson’s disease, and mood disorders. Controlling the brain with light A major goal of Boyden’s current work is to manipulate individual nerve cells using light. To do this, he takes advantage of naturally occurring light-sensitive proteins from various microorganisms, which can be artificially expressed in brain cells using genetic technology. By controlling these proteins with an implanted fiber-optic device, Boyden is developing on/off switches for brain activity. This will be a powerful way to test theories of brain function in experimental animals, and could also open the door to new clinical therapies for conditions such as epilepsy, Parkinson’s disease, or blindness.
Engineering matter and mind Ed Boyden develops new strategies for analyzing and engineering brain circuits, using synthetic biology, nanotechnology, chemistry, electrical engineering, and optics to develop broadly applicable methodologies that reveal fundamental mechanisms of complex brain processes. A major goal of his current work is the development of technologies for controlling nerve cells using light – a powerful new technology known as optogenetics that is opening the door to new treatments for conditions such as epilepsy, Parkinson’s disease, and mood disorders. Controlling the brain with light A major goal of Boyden’s current work is to manipulate individual nerve cells using light. To do this, he takes advantage of naturally occurring light-sensitive proteins from various microorganisms, which can be artificially expressed in brain cells using genetic technology. By controlling these proteins with an implanted fiber-optic device, Boyden is developing on/off switches for brain activity. This will be a powerful way to test theories of brain function in experimental animals, and could also open the door to new clinical therapies for conditions such as epilepsy, Parkinson’s disease, or blindness.